For every guideline it develops, SIGN holds a national open meeting to give the guideline development group the opportunity to present its preliminary conclusions and draft recommendations to a wider audience.
Participants are able to contribute to and influence the form of the final guideline. Often the guideline development group obtains valuable feedback, such as suggestions for additional evidence it might consider, or an alternative interpretation of the evidence.
Implementation/ launch Meetings
SIGN implementation/ launch meetings raise awareness of key issues arising from recently published guidelines.
Participants are able to contribute to the development of appropriate implementation strategies to bring about changes in clinical practice to improve outcomes among patients.